This content is machine translated Dementia risk with type 2 diabetes SGLT2 inhibitors with advantages vs. DPP4 inhibitors SGLT2 inhibitors are associated with a significantly lower risk of dementia, including Alzheimer’s disease and vascular dementia, compared to DPP4 inhibitors. The observed benefit was consistent across different subgroups and...…
View Post 4 min This content is machine translated Cannabis for schizophrenia CBD pre-treatment could exacerbate side effects A significant proportion of people with schizophrenia use cannabis, with around one in five meeting the criteria for a comorbid cannabis use disorder, for which there are still limited effective...…
View Post 7 min This content is machine translated Case study 8-year-old girl with Pätau syndrome aka trisomy 13 The median survival time for live-born children with complete trisomy 13 without medical intervention is 7-10 days. Over 90% of affected newborns die in the first year of life. Risk...…
View Post 8 min This content is machine translated Urothelial carcinoma Immune and targeted therapy options: Evidence situation 2025/2026 The treatment of urothelial carcinoma has developed significantly in recent years. Modern immunotherapies, antibody-drug conjugates (ADCs) and targeted substances complement conventional chemotherapies and increasingly enable individualized treatment strategies. New data...…
View Post 5 min This content is machine translated SGLT2 inhibitors for type 2 diabetes and CKD Prediction model beats albuminuria threshold SGLT2 inhibitors also significantly reduce the risk of kidney disease progression in patients with type 2 diabetes and preserved kidney function, whereby the relative benefit is independent of albuminuria status....…
View Post 4 min This content is machine translated Risk of psychosis Modulate cortical excitatory activity with diazepam Individuals at clinical high risk for psych osis (CHRp) have an estimated 27% chance of developing a psychotic disorder within three years, but there are currently no established preventive pharmacological...…
View Post 12 min This content is machine translated Treatable risk factor Depression and cardiovascular mortality New meta-analyses, the first ESC consensus document on mental health and heart disease and groundbreaking Lancet dataon antidepressant drugs show: Depression is an independent, quantifiable and treatable risk factor for...…
View Post 12 min This content is machine translated What are the benefits of a current review - and where do questions remain unanswered? Endometriosis and infertility Endometriosis affects an estimated 2-10% of women of reproductive age – the prevalence among infertile women is 25-50%. And yet there is still no clear, standardized treatment pathway for patients...…
View Post 15 min This content is machine translated Cardiovascular health in women Hormonal contraception, stress disorders and cardiovascular risk in women Cardiovascular disease is the leading cause of death in women, and stress-related psychiatric disorders are considered cardiovascular risk factors in their own right. Hormonal contraceptives, which are used by around...…
View Post 9 min This content is machine translated Postpartum hemorrhage What the new WHO Consensus Guidelines 2025 mean for Swiss practice On October 5, 2025 – the first World Day of Action against Postpartum Hemorrhage (PPH) – the WHO, FIGO and the International Confederation of Midwives (ICM) published the first consolidated,...…
View Post 14 min This content is machine translated Cardio-oncology When the heart pays for cancer treatment Recent studies show that cardiovascular mortality can become the leading cause of death in cancer survivors over the years. New data on ICI myocarditis, landmark cardioprotection trials and the first...…
